Kamei H - Search Results

1

Factors That Affect Continuation of Antipsychotic Long-Acting Injections.

Taniguchi M, Hatano M, Kamei H, Inagaki R, Yamada S. Taniguchi M, et al. Among authors: kamei h. Biol Pharm Bull. 2019;42(7):1098-1101. doi: 10.1248/bpb.b19-00001. Biol Pharm Bull. 2019. PMID: 31257286 Free article.

2

Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia.

Hatano M, Kamei H, Kato A, Takeuchi I, Hanya M, Uno J, Yamada S, Fujita K, Iwata N. Hatano M, et al. Among authors: kamei h. Clin Psychopharmacol Neurosci. 2017 May 31;15(2):132-137. doi: 10.9758/cpn.2017.15.2.132. Clin Psychopharmacol Neurosci. 2017. PMID: 28449560 Free PMC article.

3

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study.

Hatano M, Kamei H, Inagaki R, Matsuzaki H, Hanya M, Yamada S, Iwata N. Hatano M, et al. Among authors: kamei h. Clin Psychopharmacol Neurosci. 2018 May 31;16(2):184-189. doi: 10.9758/cpn.2018.16.2.184. Clin Psychopharmacol Neurosci. 2018. PMID: 29739132 Free PMC article.

4

The effects of different periods of co-administration of oral and long-acting injectable aripiprazole: A propensity score analysis.

Hatano M, Kamei H, Takeuchi I, Tozawa K, Makino S, Hanya M, Yamada S, Iwata N. Hatano M, et al. Among authors: kamei h. Hum Psychopharmacol. 2019 Jan;34(1):e2681. doi: 10.1002/hup.2681. Epub 2018 Nov 27. Hum Psychopharmacol. 2019. PMID: 30480343

5

Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia.

Kamei H, Homma Y, Takeuchi I, Hajitsu G, Tozawa K, Hatano M, Fukui A, Hanya M, Yamada S, Iwata N. Kamei H, et al. Clin Psychopharmacol Neurosci. 2020 Feb 29;18(1):49-57. doi: 10.9758/cpn.2020.18.1.49. Clin Psychopharmacol Neurosci. 2020. PMID: 31958905 Free PMC article.

6

Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series.

Kamei H, Yamada H, Hatano M, Hanya M, Yamada S, Iwata N. Kamei H, et al. Clin Psychopharmacol Neurosci. 2020 Feb 29;18(1):159-163. doi: 10.9758/cpn.2020.18.1.159. Clin Psychopharmacol Neurosci. 2020. PMID: 31958917 Free PMC article.

7

Trend survey on adverse event profiles of antipsychotic long-acting injections and oral agents using the Japanese adverse drug event report database.

Hatano M, Kamei H, Shimato A, Yamada S, Iwata N. Hatano M, et al. Among authors: kamei h. Psychiatry Res. 2020 Sep;291:113249. doi: 10.1016/j.psychres.2020.113249. Epub 2020 Jun 23. Psychiatry Res. 2020. PMID: 32603929

8

Satisfaction Survey on Antipsychotic Formulations by Schizophrenia Patients in Japan.

Hatano M, Takeuchi I, Yamashita K, Morita A, Tozawa K, Sakakibara T, Hajitsu G, Hanya M, Yamada S, Iwata N, Kamei H. Hatano M, et al. Among authors: kamei h. Clin Psychopharmacol Neurosci. 2021 Nov 30;19(4):610-617. doi: 10.9758/cpn.2021.19.4.610. Clin Psychopharmacol Neurosci. 2021. PMID: 34690116 Free PMC article.

9

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia.

Kamei H. Kamei H. Medicina (Kaunas). 2022 Nov 3;58(11):1584. doi: 10.3390/medicina58111584. Medicina (Kaunas). 2022. PMID: 36363541 Free PMC article. Review.

10

Effect of Adenine on Clozapine-induced Neutropenia in Patients with Schizophrenia: A Preliminary Study.

Takeuchi I, Kishi T, Hanya M, Uno J, Fujita K, Kamei H. Takeuchi I, et al. Among authors: kamei h. Clin Psychopharmacol Neurosci. 2015 Aug 31;13(2):157-62. doi: 10.9758/cpn.2015.13.2.157. Clin Psychopharmacol Neurosci. 2015. PMID: 26243842 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

456 results

Search Page

Filters